PDF factsheet
      Z

increasing hemoglobin concentration in acute myocardial infarction for patients undergoing PCI, clinical trials results

epoetin alfa versus placebo
HEBE III, 2010
single bolus of 60,000 IU epoetin alfa administered intravenously within three hours after a successful PCI
versus
control
patients with a first ST-elevation MI and a successful PCI open
Follow-up duration: 6 weeks
the Netherlands
erythropoietin versus placebo
REVEAL,
NCT00378352
Single parenteral administration of erythropoietin at 15,000 Units, 30,000 Units, or 60,000 Units
versus
placebo
patients after large myocardial infarction double-blind
recombinant human erythropoietin beta versus placebo
REVIVAL-3,
NCT00390832
recombinant human erythropoietin beta 33.333 IU given at 3 time points (immediately, 24 hours and 48 hours after percutaneous coronary intervention)
versus
placebo
patients with ST-elevation myocardial infarction undergoing percutaneous coronary interventiondouble-blind
Germany

  Options


in first

in second

  Filter